vs
黑莓（BB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是黑莓的1.4倍（$197.9M vs $141.8M），黑莓净利率更高（9.7% vs 6.7%，领先2.9%），REPLIGEN CORP同比增速更快（13.6% vs -0.8%），REPLIGEN CORP自由现金流更多（$17.6M vs $17.4M），过去两年黑莓的营收复合增速更高（17.8% vs 14.4%）
黑莓有限公司（前身为动态研究公司，简称RIM）是加拿大专注于安全通信与物联网领域的软件企业，成立于1984年。早年曾推出黑莓品牌双向寻呼机、智能手机及平板电脑产品，后续转型提供软件与服务，拥有多项核心软件应用专利。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BB vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$141.8M
营收增速更快
RGEN
高出14.5%
-0.8%
净利率更高
BB
高出2.9%
6.7%
自由现金流更多
RGEN
多$151.0K
$17.4M
两年增速更快
BB
近两年复合增速
14.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.8M | $197.9M |
| 净利润 | $13.7M | $13.3M |
| 毛利率 | 77.5% | 52.5% |
| 营业利润率 | 8.4% | 9.0% |
| 净利率 | 9.7% | 6.7% |
| 营收同比 | -0.8% | 13.6% |
| 净利润同比 | 224.5% | 143.9% |
| 每股收益（稀释后） | $0.02 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBRGEN
| Q4 25 | $141.8M | $197.9M | ||
| Q3 25 | $129.6M | $188.8M | ||
| Q2 25 | $121.7M | $182.4M | ||
| Q1 25 | $141.7M | $169.2M | ||
| Q4 24 | $143.6M | $174.1M | ||
| Q3 24 | $126.2M | $154.9M | ||
| Q2 24 | $123.4M | $154.1M | ||
| Q1 24 | $102.1M | $151.3M |
净利润BBRGEN
| Q4 25 | $13.7M | $13.3M | ||
| Q3 25 | $13.3M | $14.9M | ||
| Q2 25 | $1.9M | $14.9M | ||
| Q1 25 | $-7.4M | $5.8M | ||
| Q4 24 | $-10.5M | $-30.3M | ||
| Q3 24 | $-19.7M | $-654.0K | ||
| Q2 24 | $-41.4M | $3.3M | ||
| Q1 24 | $-56.2M | $2.1M |
毛利率BBRGEN
| Q4 25 | 77.5% | 52.5% | ||
| Q3 25 | 74.5% | 53.2% | ||
| Q2 25 | 74.2% | 50.0% | ||
| Q1 25 | 73.5% | 53.6% | ||
| Q4 24 | 78.1% | 26.1% | ||
| Q3 24 | 70.2% | 50.0% | ||
| Q2 24 | 72.9% | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率BBRGEN
| Q4 25 | 8.4% | 9.0% | ||
| Q3 25 | 8.9% | 8.9% | ||
| Q2 25 | 1.6% | 7.6% | ||
| Q1 25 | -5.6% | 3.9% | ||
| Q4 24 | 13.6% | -17.7% | ||
| Q3 24 | 1.7% | -5.1% | ||
| Q2 24 | -10.5% | 1.0% | ||
| Q1 24 | 50.0% | 1.3% |
净利率BBRGEN
| Q4 25 | 9.7% | 6.7% | ||
| Q3 25 | 10.3% | 7.9% | ||
| Q2 25 | 1.6% | 8.2% | ||
| Q1 25 | -5.2% | 3.4% | ||
| Q4 24 | -7.3% | -17.4% | ||
| Q3 24 | -15.6% | -0.4% | ||
| Q2 24 | -33.5% | 2.2% | ||
| Q1 24 | -55.0% | 1.4% |
每股收益（稀释后）BBRGEN
| Q4 25 | $0.02 | $0.24 | ||
| Q3 25 | $0.02 | $0.26 | ||
| Q2 25 | $0.00 | $0.26 | ||
| Q1 25 | $-0.01 | $0.10 | ||
| Q4 24 | $-0.02 | $-0.55 | ||
| Q3 24 | $-0.03 | $-0.01 | ||
| Q2 24 | $-0.07 | $0.06 | ||
| Q1 24 | $-0.08 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.2M | $767.6M |
| 总债务越低越好 | $196.2M | $542.2M |
| 股东权益账面价值 | $741.1M | $2.1B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.26× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BBRGEN
| Q4 25 | $304.2M | $767.6M | ||
| Q3 25 | $290.5M | $748.7M | ||
| Q2 25 | $306.6M | $708.9M | ||
| Q1 25 | $337.8M | $697.2M | ||
| Q4 24 | $220.0M | $757.4M | ||
| Q3 24 | $211.0M | $784.0M | ||
| Q2 24 | $229.0M | $809.1M | ||
| Q1 24 | $237.1M | $780.6M |
总债务BBRGEN
| Q4 25 | $196.2M | $542.2M | ||
| Q3 25 | $195.9M | $537.9M | ||
| Q2 25 | $195.6M | — | ||
| Q1 25 | $195.3M | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $194.1M | — |
股东权益BBRGEN
| Q4 25 | $741.1M | $2.1B | ||
| Q3 25 | $725.1M | $2.1B | ||
| Q2 25 | $725.1M | $2.1B | ||
| Q1 25 | $719.9M | $2.0B | ||
| Q4 24 | $725.2M | $2.0B | ||
| Q3 24 | $732.1M | $2.0B | ||
| Q2 24 | $742.6M | $2.0B | ||
| Q1 24 | $775.1M | $2.0B |
总资产BBRGEN
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $1.3B | $2.8B | ||
| Q3 24 | $1.3B | $2.8B | ||
| Q2 24 | $1.3B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
负债/权益比BBRGEN
| Q4 25 | 0.26× | 0.26× | ||
| Q3 25 | 0.27× | 0.26× | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.25× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $17.4M | $17.6M |
| 自由现金流率自由现金流/营收 | 12.3% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.34× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $42.8M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BBRGEN
| Q4 25 | $18.3M | $25.7M | ||
| Q3 25 | $3.9M | $48.1M | ||
| Q2 25 | $-18.0M | $28.6M | ||
| Q1 25 | $41.6M | $15.0M | ||
| Q4 24 | $6.0M | $39.2M | ||
| Q3 24 | $-16.0M | $49.3M | ||
| Q2 24 | $-15.1M | $42.2M | ||
| Q1 24 | $-15.5M | $44.7M |
自由现金流BBRGEN
| Q4 25 | $17.4M | $17.6M | ||
| Q3 25 | $3.1M | $43.4M | ||
| Q2 25 | $-18.9M | $21.5M | ||
| Q1 25 | $41.2M | $11.4M | ||
| Q4 24 | $5.2M | $33.6M | ||
| Q3 24 | $-16.5M | $42.3M | ||
| Q2 24 | $-16.5M | $37.4M | ||
| Q1 24 | $-17.6M | $36.4M |
自由现金流率BBRGEN
| Q4 25 | 12.3% | 8.9% | ||
| Q3 25 | 2.4% | 23.0% | ||
| Q2 25 | -15.5% | 11.8% | ||
| Q1 25 | 29.1% | 6.8% | ||
| Q4 24 | 3.6% | 19.3% | ||
| Q3 24 | -13.1% | 27.3% | ||
| Q2 24 | -13.4% | 24.3% | ||
| Q1 24 | -17.2% | 24.0% |
资本支出强度BBRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | 0.7% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 0.6% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% | ||
| Q1 24 | 2.1% | 5.5% |
现金转化率BBRGEN
| Q4 25 | 1.34× | 1.93× | ||
| Q3 25 | 0.29× | 3.23× | ||
| Q2 25 | -9.47× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BB
| QNX | $68.7M | 48% |
| Secure Communication | $67.0M | 47% |
| Licensing | $6.1M | 4% |
RGEN
暂无分部数据
